22 results
8-K
EX-99.1
HEPA
Hepion Pharmaceuticals Inc
28 Jun 22
Departure of Directors or Certain Officers
9:46am
and reimbursement of three innovative cancer drugs – Blincyto®, Jevtana® and Votrient® – in the U.S., EU and MENA regions, with a focus on global medical
8-K
EX-99.1
r2260hlw45o
9 Jun 21
Hepion Pharmaceuticals to be Added to the Russell Microcap® Index
9:06am
10-KT
crp144k0q w0o9wkn
26 Mar 18
Annual report (with FYE transition)
12:00am
424B5
hovuh g2c2ar3xt8cn6
7 Oct 15
Prospectus supplement for primary offering
12:00am
8-K
EX-99.1
ptdrk 5esg0nylhz1qsl
15 Jan 15
ContraVir Pharmaceuticals Appoints John Sullivan-Bolyai, M.D., MPH, as Chief Medical Officer
12:00am
10-K
2p39zsfft5i
29 Sep 14
Annual report
12:00am
10-12G/A
EX-99.1
kpu2j
6 Feb 14
Registration of securities (amended)
12:00am
10-12G/A
EX-99.1
6n70x
24 Dec 13
Registration of securities (amended)
12:00am
10-12G/A
EX-99.1
0709na9xr0h1
21 Nov 13
Registration of securities (amended)
12:00am
10-12G/A
EX-99.1
ulhey0xe5ynsta0toa8
22 Oct 13
Registration of securities (amended)
12:00am